Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 18636152)

1.

Prevention and delay in progression of human pancreatic cancer by stable overexpression of the opioid growth factor receptor.

Zagon IS, Kreiner S, Heslop JJ, Conway AB, Morgan CR, McLaughlin PJ.

Int J Oncol. 2008 Aug;33(2):317-23.

PMID:
18636152
3.

Overexpression of the opioid growth factor receptor potentiates growth inhibition in human pancreatic cancer cells.

Zagon IS, Verderame MF, Hankins J, McLaughlin PJ.

Int J Oncol. 2007 Apr;30(4):775-83.

PMID:
17332915
4.
5.
7.

Under-expression of the opioid growth factor receptor promotes progression of human ovarian cancer.

Donahue RN, McLaughlin PJ, Zagon IS.

Exp Biol Med (Maywood). 2012 Feb;237(2):167-77. doi: 10.1258/ebm.2011.011321. Epub 2012 Feb 10.

PMID:
22328595
8.

Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers.

Zagon IS, Donahue RN, McLaughlin PJ.

Am J Physiol Regul Integr Comp Physiol. 2009 Oct;297(4):R1154-61. doi: 10.1152/ajpregu.00414.2009. Epub 2009 Aug 12.

9.

Cell proliferation of human ovarian cancer is regulated by the opioid growth factor-opioid growth factor receptor axis.

Donahue RN, McLaughlin PJ, Zagon IS.

Am J Physiol Regul Integr Comp Physiol. 2009 Jun;296(6):R1716-25. doi: 10.1152/ajpregu.00075.2009. Epub 2009 Mar 18.

10.

Defects in the opioid growth factor receptor in human squamous cell carcinoma of the head and neck.

McLaughlin PJ, Stack BC Jr, Levin RJ, Fedok F, Zagon IS.

Cancer. 2003 Apr 1;97(7):1701-10.

11.
12.

The OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancer.

Cheng F, McLaughlin PJ, Verderame MF, Zagon IS.

Mol Cancer. 2008 Jan 11;7:5. doi: 10.1186/1476-4598-7-5.

13.

Expression of opioid growth factor (OGF)-OGF receptor (OGFr) axis in human nonmedullary thyroid cancer.

Goldenberg D, Zagon IS, Fedok F, Crist HS, McLaughlin PJ.

Thyroid. 2008 Nov;18(11):1165-70. doi: 10.1089/thy.2008.0112.

PMID:
19014324
14.

Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis.

McLaughlin PJ, Zagon IS, Park SS, Conway A, Donahue RN, Goldenberg D.

BMC Cancer. 2009 Oct 18;9:369. doi: 10.1186/1471-2407-9-369.

15.

The functional significance of the cholecystokinin-C (CCK-C) receptor in human pancreatic cancer.

Smith JP, Stanley WB, Verderame MF, Zagon IS.

Pancreas. 2004 Nov;29(4):271-7.

PMID:
15502642
16.

Opioid growth factor (OGF) inhibits human pancreatic cancer transplanted into nude mice.

Zagon IS, Hytrek SD, Smith JP, McLaughlin PJ.

Cancer Lett. 1997 Jan 30;112(2):167-75.

PMID:
9066724
17.

The expression and function of the OGF-OGFr axis - a tonically active negative regulator of growth - in COS cells.

Zagon IS, Verderame MF, McLaughlin PJ.

Neuropeptides. 2003 Oct;37(5):290-7.

PMID:
14607106
18.

Opioid growth factor regulates the cell cycle of human neoplasias.

Zagon IS, Roesener CD, Verderame MF, Ohlsson-Wilhelm BM, Levin RJ, McLaughlin PJ.

Int J Oncol. 2000 Nov;17(5):1053-61.

PMID:
11029512
19.

Particle-mediated gene transfer of opioid growth factor receptor cDNA regulates cell proliferation of the corneal epithelium.

Zagon IS, Sassani JW, Verderame MF, McLaughlin PJ.

Cornea. 2005 Jul;24(5):614-9.

PMID:
15968171
20.

T lymphocyte proliferation is suppressed by the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: implication for the treatment of autoimmune diseases.

Zagon IS, Donahue RN, Bonneau RH, McLaughlin PJ.

Immunobiology. 2011 May;216(5):579-90. doi: 10.1016/j.imbio.2010.09.014. Epub 2010 Sep 29.

PMID:
20965606
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk